MET | MetLifeNYSEFinancialCommon stock golden cross and death cross projections, cross tests and history

$100.67
-$0.27 (-0.27%)

MetLife (MET) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $100.67 vs 50 $97.90 / 200 $85.92
Projection
No cross projected
Test
No active test
Last cross
Golden cross 5 Jun 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $100.02 vs 50 $84.63 / 200 $75.03
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 3 May 2021 ยท projected 30 bars out

4-hour as of 3 Nov 13:30 ET

Price
above both $100.94 vs 50 $99.00 / 200 $95.18
Projection
No cross projected
Test
No active test
Last cross
Golden cross 6 May 2026 bar 1 ยท projected 27 bars out ยท tested 1 bar

Cross history

37
crosses on record since 2017
19 golden18 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
5 Jun 2026Golden steepdaily30 bars outNot tested
6 May 2026Golden4-hour27 bars out1 bar cross test
25 Feb 2026Death flatdaily7 bars outNot tested
3 Feb 2026Golden flatdaily3 bars out5 bar cross test
28 Jan 2026Death flatdaily3 bars out3 bar cross test

About MET

ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$282M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorFinancial
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.